Portage Biotech INC 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
Alpha Compute Corp. filed an amendment to its annual report to correct administrative errors, revealing significant net losses and substantial increases in operating expenses, while also reiterating substantial doubt about its ability to continue as a going concern.
20-F: Portage Biotech Faces Going Concern Doubts Amid Strategic Restructuring and Clinical Program Pauses
Portage Biotech reported a significantly reduced net loss in Fiscal 2025 but continues to face substantial doubt about its ability to continue as a going concern, driven by ongoing capital constraints and strategic realignments of its clinical pipeline.
Portage Biotech initiates strategic review, including potential asset sales or merger, due to funding challenges and discontinuation of certain clinical trials.